Multi-Tissue Platform MTP ® Technology

The Potential to Transform Medicine & Millions of Lives

FetTech’s MTP Platform is at the very forefront of regenerative medicine, helping to translate groundbreaking scientific discovery into actionable clinical therapies.

There are unlimited life-changing possibilities using our MTP technology that teaches the body to heal better and faster, wherever there’s an injury. 

How does MTP work:

MTP provides the body with the tools and instructions to heal itself. Each patient has unique genetics, each injury is a unique challenge for the body to repair. For example, a surgical incision, a non-healing chronic wound, and damage heart muscle from a heart attack each have different needs in order to heal properly.

MTP takes advantage of the signaling components and biomolecules present in naturally derived tissue to enhance and support the body’s own regenerative capabilities.

✔ Stable with an ambient temperature and long shelf life

✔ Naturally derived and cell free

✔ Enhances healing and targets aging without the downtime, scarring or inflammation

✔ Easy to apply and can cover even the most irregular shaped treatment areas

✔ Versatile, lending itself to a broad pipeline

✔ 1,000s of safe clinical applications

Benefits

​​Created from multiple extracellular matrix (ECM) tissues, each ECM tissue contains a wide variety of natural biomolecules, including:

  • COLLAGEN TYPES I,III, IV, V

  • LAMININ

  • ELASTIN

  • FIBRONECTIN

  • FIBROBLAST GROWTH FACTOR (FGF)

  • VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)

  • EPIDERMAL GROWTH FACTOR (EGF)

  • EXOSOMES

  • HYALURONIC ACID

These and other biomolecules facilitate repair by providing the binding sites and signaling molecules necessary to recruit stem cells and other important cell types to the site of injury, modulating the body’s inflammatory response. Additionally, many of these biomolecules are themselves building blocks of new functional tissue, and applying MTP ensures that the body has plenty of the material it needs in order to repair.

To date, ECM products have been derived from one tissue source, limiting the quantity and variety of biomolecules in the medical device. The team at FetTech is the first in the world to overcome the previous limitations of tissue devices, by combining multiple tissue sources, providing the body access to more biomolecules, and enhancing and supporting the body’s own reparative and regenerative capabilities.